FDA Authorizes Marketing of First Diagnostic Test for Zika Virus Antibodies
The marketing authorization does not impact the availability of the 14 other Zika nucleic acid diagnostics available under EUAs. Today, ...
Tag: Editor Pick
Daiichi Sankyo Apologizes for Not Meeting Vaccine Production Milestone for Pandemic Preparedness
Daiichi Sankyo announced in an official statement on 17 May that the Company has been unable to fulfill its obligation ...
Portable Isolation Unit: Coast Guard-Developed System for Evacuating Infectious or Contaminated Patients
The Ebola outbreak of 2014-2015 was notable for a number of important reasons: it was the largest outbreak in history, ...
Phage Therapy to Prevent Cholera Infections – and Possibly Those Caused by Other Deadly Bacteria
In the latest of a string of high-profile cases in the U.S., a cocktail of bacteria-killing viruses successfully treated a ...
Cyberbiosecurity Challenges of Pathogen Genome Databases
Pathogen detection, identification, and tracking is shifting from non-molecular methods, DNA fingerprinting methods, and single gene methods to methods relying ...
Ebola Situation Worsening and Still Only Half of Response Budget is Funded
Only half of the requested funds for the Ebola crisis response in the Democratic Republic of the Congo have been ...
Radiation Nuclear Countermeasures Centralized Dosimetry Harmonization Effort
NIAID’s Radiation Nuclear Countermeasures Program (RNCP) seeks support to assess current methodology and variations in radiation dosing in in vivo and in vitro studies ...
Ology Bioservices Awarded DoD Contract for Countermeasures Against Bioweapons
The Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded Ology ...
BARDA Extends Strategic Partnership with JLABS
The Biomedical Advanced Research and Development Authority (BARDA) will collaborate with Johnson & Johnson Innovation – JLABS to develop and ...
Biodefense Summit: Implementing the National Biodefense Strategy
Biological threats are among the most serious threats facing the United States. In today's interconnected world, biological incidents have the ...
Next Generation Biosecurity Open Online Course
An open online course exploring biosecurity and biological threats begins this week on FutureLearn. This course is for professionals working ...
Counterfeit Medications: What We Know and What Needs to be Done
Nigerian health authorities found a fake version of a meningitis A vaccine, branded Mencevax, on March 15th after the Niger’s health department ...
Assessing Cyberbiosecurity Vulnerabilities and Infrastructure Resilience
Daniel S. Schabacker, Nate J. Evans, Jennifer M. Fowler and Ellen A. Dickey work at the Argonne National Laboratory (DOE), ...
World Health Organization Releases Global Influenza Strategy for 2019-2030
The World Health Organization has released its Global Influenza Strategy for 2019-2030, which provides a framework “for WHO, countries and ...
Non-Medical Obstacles Impacting Public Health Responses
The standard view of public health usually involves the portrayal of health care workers in lab coats peering into microscopes ...
Why the Scientific Debate Over a UW Bird Flu Study Isn’t Going Away
A University of Wisconsin-Madison laboratory is set to resume experiments that could build the foundation of an early warning system ...
‘TIS the Way to Transport a Highly Contagious Patient by Air
U.S. Air Force personnel conducted training on the Transportation Isolation System (TIS), an enclosure the Defense Department can use to ...
#ThisISOurLane: Gun Violence and the Role of Infectious Diseases Clinicians
A tweet from the National Rifle Association (NRA) advising “self-important anti-gun doctors to stay in their lane,” has prompted physicians ...
CDC Fiscal Year 2019 Broad Agency Announcement
The Centers for Disease Control and Prevention (CDC) works with its partners to monitor health, detect and investigate health problems, ...
Whooping Cough: Tulane Awarded $8.5M to Develop Next-Generation Pertussis Vaccine
Tulane University researchers are developing a vaccine formulation that may provide longer lasting immunity in fewer doses against pertussis, more ...
